Skip to content

Reducing Radiation Exposure to Operators During Invasive Cardiac Procedures

Reducing Radiation Exposure to Operators During Invasive Cardiac Procedures With a Novel Lead-Based Arm-Board

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03605030
Acronym
RADAR
Enrollment
360
Registered
2018-07-30
Start date
2017-05-29
Completion date
2018-05-30
Last updated
2018-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients Undergoing Invasive Cardiac Procedures, Radiation Exposure

Keywords

Cardiac Catheterization, Percutaneous Coronary Intervention, Radiation, Lead Shielding

Brief summary

The primary objective of this study is to determine if a novel lead-based arm board is effective at reducing radiation dose to the operator during invasive cardiac procedures. Secondary objectives are to measure effect on radiation dose to patient and total fluoroscopy (x-ray) time.

Interventions

DEVICENovel Lead Based Armboard

Novel Lead Based Armboard

DEVICEStandard Armboard

Standard Armboard (without lead)

Sponsors

Western University, Canada
CollaboratorOTHER
London Health Sciences Centre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> 18 * Planned invasive cardiology procedure, cardiac catheterization with or without percutaneous coronary intervention (PCI), or PCI alone.

Exclusion criteria

* Inability to provide consent

Design outcomes

Primary

MeasureTime frameDescription
Radiation dose (μSv) to the operator at the chestAt procedure completionCo-primary outcomes included radiation dose (μSv; mean ± SD) to the operator at the chest and forearm level.
Radiation dose (μSv) to the operator at the forearm levelAt procedure completionCo-primary outcomes included radiation dose (μSv; mean ± SD) to the operator at the chest and forearm level.

Secondary

MeasureTime frame
Air kermaAt procedure completion
Dose area productAt procedure completion
Radiation dose to the patientAt procedure completion

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026